Diamedica Therapeutics Inc

DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.

Address Details

Address: 2 CARLSON PARKWAY SUITE 260

City: MINNEAPOLIS

State: MN

Country: USA

Zip Code: 55447